Quince Therapeutics President Charles Ryan to depart Sept 8, 2026

Quince Therapeutics, Inc.

President Charles Ryan's last day of employment is September 8, 2026; departure announced August 23, 2026.
Ryan eligible for severance under Executive Change in Control and Severance Agreement dated September 1, 2023.
Severance terms described in definitive proxy statement filed August 25, 2026.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles Ryan

President

QNCX · Quince Therapeutics, Inc.

Effective: 2026-09-08
Filed: August 27, 2026, 4:30 PM ET

On August 23, 2026, Quince Therapeutics, Inc. (the “Company”) and Charles Ryan, the Company’s President, determined that Mr. Ryan’s last day of employment will be September 8, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles Ryan departed as President at Quince Therapeutics, Inc..

Action: determined
Role: President

Exact text from the filing

On August 23, 2026, Quince Therapeutics, Inc. (the “Company”) and Charles Ryan, the Company’s President, determined that Mr. Ryan’s last day of employment will be September 8, 2026.

View on SEC.gov

Quince Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-371389

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.